1. Microarray Gene Expression Analysis of Fixed Archival Tissue Permits Molecular Classification and Identification of Potential Therapeutic Targets in Diffuse Large B-Cell Lymphoma
   Kim Linton et al, 2012, The Journal of Molecular Diagnostics CrossRef
2. Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients
   Beibei Lu et al, 2011, Leukemia & Lymphoma CrossRef
3. Role of MUM-1 immunohistochemistry in prognosis of primary gastrointestinal diffuse large cell lymphoma
   Kavita Gupta et al, 2021, Indian Journal of Pathology and Oncology CrossRef
4. STAT3 Targets Suggest Mechanisms of Aggressive Tumorigenesis in Diffuse Large B-Cell Lymphoma
   Jennifer Hardee et al, 2013, G3 Genes|Genomes|Genetics CrossRef
5. Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL
   Yocanxóchitl Perfecto-Avalos et al, 2019, Journal of Translational Medicine CrossRef
6. Quality Initiative in Clinical Practice: A Single-Institution Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma
   Alina M. Bischin et al, 2019, Mayo Clinic Proceedings: Innovations, Quality & Outcomes CrossRef
7. DLBCL Subtypes and Prognosis Based on Immunophenotyping
   Linu Abraham Jacob et al, 2024, Advances in Hematological Malignancies CrossRef
8. Evaluation of Clinical and Biological Prognostic Factors in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients After Previous Treatment With Rituximab and Chemotherapy: Results of the PRO-R-IPI Study
   Carlos Panizo et al, 2015, Clinical Lymphoma Myeloma and Leukemia CrossRef
9. QuantiGene Plex Represents a Promising Diagnostic Tool for Cell-of-Origin Subtyping of Diffuse Large B-Cell Lymphoma
   John S. Hall et al, 2015, The Journal of Molecular Diagnostics CrossRef